U.S. market Closed. Opens in 10 hours 51 minutes

MDGL | Madrigal Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A147.00K7.58M14.80M144.25M2.62M743.00KN/AN/A173.00K1.30MN/AN/A
Cost of Revenue527.00K467.00K405.00K471.00K112.00K96.00K77.00K156.00N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-527.00K-467.00K-405.00K-471.00K-112.00K-96.00K-77.00K-156.00N/AN/AN/A147.00K7.58M14.80M144.25M2.62M743.00KN/AN/A173.00K1.30MN/AN/A
Operating Expenses380.50M293.57M242.48M206.67M94.97M40.68M32.06M25.22M67.61M83.95M87.56M61.09M53.02M51.70M63.70M96.32M66.96M59.15M71.18M45.52M29.60M7.29M401.00K
Selling, General & Admin108.15M48.13M37.32M21.86M22.65M15.29M7.67M9.29M13.39M15.75M15.70M11.68M11.55M11.45M12.65M14.74M14.93M8.65M11.28M7.38M5.26MN/A124.00K
Research & Development272.35M245.44M205.16M184.81M72.32M25.39M24.39M15.93M54.22M68.20M71.86M49.41M41.46M40.25M51.05M81.58M52.02M50.50M59.90M38.14M24.34M7.29M277.00K
Other Operating ExpensesN/AN/A273.00K100.00KN/A200.00K350.00KN/AN/AN/AN/AN/AN/AN/A1.24MN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-380.50M-293.57M-242.48M-206.67M-94.97M-40.68M-32.06M-25.22M-67.61M-83.95M-87.56M-60.94M-45.43M-36.90M79.30M-93.71M-66.22M-59.15M-71.18M-46.93M-28.29M-36.26M-401.00K
Other Expenses / Income6.87M-1.78M636.00K4.43M11.02M7.87M908.00K-1.16M60.77M-2.21M-2.63M-1.85M-1.95M-569.00K-216.00K1.09M2.72M22.00K2.32M-588.00K416.00K-18.09MN/A
Before Tax Income-373.63M-295.35M-241.85M-202.24M-83.95M-32.81M-31.15M-26.39M-68.67M-86.16M-90.19M-62.79M-47.38M-37.47M79.09M-92.62M-122.08M-59.13M-68.86M-47.52M-27.88M-54.35MN/A
Income Tax ExpensesN/A3.96M-768.00K-4.80M-11.14M7.87M-635.00K-373.00N/AN/AN/AN/AN/AN/A1.45MN/A-2.72M-1.88M-2.32M588.00K-416.00K-18.20M381.00K
Net Income-373.63M-299.31M-241.08M-197.44M-72.81M-32.81M-31.15M-26.39M-68.67M-86.16M-90.19M-62.79M-47.38M-37.47M79.09M-92.62M-63.49M-57.27M-68.86M-45.93M-27.88M-36.15M-381.00K
Interest Expenses12.71M3.96MN/AN/A11.02M7.67M558.00K1.16M1.06M2.21M2.63M1.85M1.95M569.00K312.00K489.00KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding18.69M17.14M16.54M15.45M15.39M14.80M12.24M5.20M171.01K2.81M2.03M1.70M1.35M1.15M968.21K963.86K927.59K636.14K635.80K534.39K624.37K344.04K83.73K
Diluted Shares Outstanding18.69M17.14M16.54M15.45M15.39M14.80M12.24M5.20M171.01K2.81M2.03M1.70M1.35M1.15M974.81K963.86K927.59K636.14K635.80K534.39K624.37K344.04K83.73K
EBITDA-379.97M-293.10M-242.08M-206.20M-94.86M-40.59M-31.98M-22.52M-3.23M-83.28M-87.04M-60.20M-43.97M-34.97M81.86M-90.99M-62.87M-53.62M-71.04M-43.80M-27.29M10.80M-401.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-40,954.42%-579.75%-236.20%56.75%-3,479.58%-8,460.97%0.00%0.00%-25,317.34%-2,092.64%0.00%0.00%
EBIT-360.92M-291.39M-241.85M-202.24M-72.92M-17.27M-31.23M-25.22M-67.61M-83.95M-87.56M-60.94M-45.43M-36.90M80.85M-92.13M-66.22M-59.15M-71.18M-45.35M-28.29M-54.35MN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-41,456.46%-599.05%-249.26%56.05%-3,523.10%-8,911.98%0.00%0.00%-26,211.56%-2,169.79%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙